T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.45B |
| 2 |
Pinterest
PINS
|
+$1.89B |
| 3 |
T-Mobile US
TMUS
|
+$1.89B |
| 4 |
Zoom
ZM
|
+$1.77B |
| 5 |
UiPath
PATH
|
+$1.71B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$3.66B |
| 2 |
Caterpillar
CAT
|
+$1.32B |
| 3 |
Netflix
NFLX
|
+$1.18B |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.15B |
| 5 |
Micron Technology
MU
|
+$1.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.62% |
| 2 | Healthcare | 16.07% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Communication Services | 13.46% |
| 5 | Financials | 12.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AZPN
876
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $78.4M | 0.01% |
570,266
-25,148
| -4% | -$3.46M |
|
877
Lantheus
LNTH
$6.57B
| $78.2M | 0.01% |
2,829,314
-71,322
| -2% | -$1.64M |
|
878
Teradyne
TER
$64.2B
| $78.1M | 0.01% |
583,219
-7,989
| -1% | -$1.02M |
|
879
Constellation Brands
STZ
$22.9B
| $77.4M | 0.01% |
330,835
-9,304
| -3% | -$2.18M |
|
880
Repay Holdings
RPAY
$311M
| $76.8M | 0.01% |
3,192,671
+174,269
| +6% | +$4.08M |
|
881
DTE Energy
DTE
$28.9B
| $76.4M | 0.01% |
693,006
-1,641,903
| -70% | -$192M |
|
882
Floor & Decor
FND
$6.32B
| $76.1M | 0.01% |
720,067
+352,368
| +96% | +$36.6M |
|
883
Tandem Diabetes Care
TNDM
$1.63B
| $76.1M | 0.01% |
781,343
-312,972
| -29% | -$27.9M |
|
|
ACCD
884
DELISTED
Accolade Inc
ACCD
| $75.9M | 0.01% |
1,397,223
+557,549
| +66% | +$27.1M |
|
885
Emcor
EME
$36.8B
| $75.5M | 0.01% |
613,227
-1,790
| -0.3% | -$218K |
|
886
Power Integrations
POWI
$3.57B
| $75.5M | 0.01% |
920,583
-3,099
| -0.3% | -$250K |
|
887
Dow Inc
DOW
$21.9B
| $75.3M | 0.01% |
1,190,520
-327
| -0% | -$21.6K |
|
|
INFO
888
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $74.9M | 0.01% |
664,659
-553
| -0.1% | -$58.7K |
|
889
Paychex
PAYX
$42.8B
| $74.8M | 0.01% |
697,358
-10,708
| -2% | -$1.08M |
|
890
Onto Innovation
ONTO
$20.6B
| $74.2M | 0.01% |
1,015,965
+41,600
| +4% | +$2.86M |
|
|
DRNA
891
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $74M | 0.01% |
1,982,925
+289,743
| +17% | +$8.88M |
|
|
PGTI
892
DELISTED
PGT, Inc.
PGTI
| $74M | 0.01% |
3,183,588
-168,540
| -5% | -$4.18M |
|
893
Celanese
CE
$4.75B
| $73.3M | 0.01% |
483,758
-311,037
| -39% | -$49.4M |
|
894
Republic Services
RSG
$65.6B
| $73.3M | 0.01% |
666,006
+260,582
| +64% | +$28M |
|
895
SPS Commerce
SPSC
$2.86B
| $73.1M | 0.01% |
732,431
+44,956
| +7% | +$4.44M |
|
896
TG Therapeutics
TGTX
$7.58B
| $73.1M | 0.01% |
1,883,651
+266,310
| +16% | +$10.5M |
|
|
PLAN
897
DELISTED
Anaplan, Inc.
PLAN
| $72.9M | 0.01% |
1,368,174
+103,722
| +8% | +$5.77M |
|
898
SLB Ltd
SLB
$78.1B
| $72.9M | 0.01% |
2,276,204
-40,706
| -2% | -$1.25M |
|
899
Watsco Inc
WSO
$12.8B
| $72.9M | 0.01% |
254,163
-778
| -0.3% | -$223K |
|
900
eBay
EBAY
$45.5B
| $72.7M | 0.01% |
1,035,578
-14,085
| -1% | -$883K |
|
Similar funds
T. Rowe Price Associates's Q2 2021 Portfolio in Review
As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
- T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
- T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
- T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
- T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
- T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.
Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.